M
Maciej Szmitkowski
Researcher at Medical University of Białystok
Publications - 281
Citations - 4932
Maciej Szmitkowski is an academic researcher from Medical University of Białystok. The author has contributed to research in topics: Cancer & Aldehyde dehydrogenase. The author has an hindex of 33, co-authored 280 publications receiving 4330 citations.
Papers
More filters
Journal ArticleDOI
Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies
Michal Ciborowski,Monika Zbucka-Kretowska,Dorota Bomba-Opoń,Miroslaw Wielgos,Robert Brawura-Biskupski-Samaha,Piotr Pierzynski,Maciej Szmitkowski,Slawomir Wolczynski,Danuta Lipinska,Anna Citko,Witold Bauer,Maria Gorska,Adam Kretowski +12 more
TL;DR: Evaluated metabolomic serum profiles of healthy pregnant women were evaluated to identify early biomarkers of macrosomia and LBW and to understand mechanisms leading to abnormal fetal growth not related to mother's body mass index or presence of gestational diabetes.
Journal ArticleDOI
Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with liver cancer
TL;DR: A statistically significant increase of class I ADH isoenzymes was found in the sera of cancer patients, and this increase of activity seems to be caused by the enzyme released from liver cancer cells and primary tumors originating in other organs.
Journal ArticleDOI
Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer.
TL;DR: The results suggest that M-CSF is a better candidate for a pancreatic cancer tumor marker than SCF.
Journal ArticleDOI
The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in breast cancer.
TL;DR: The decrease of activity of class I ADH isoenzyme in breast cancer tissues may be a factor of some disorders in metabolic pathways with participation of these isoenzymes that can lead to carcinogenesis.
Journal ArticleDOI
Evaluation of Visinin-Like Protein 1 Concentrations in the Cerebrospinal Fluid of Patients with Mild Cognitive Impairment as a Dynamic Biomarker of Alzheimer's Disease
Barbara Mroczko,Magdalena Groblewska,Marzena Zboch,Paweł Muszyński,Agata Zajkowska,Renata Borawska,Maciej Szmitkowski,Johannes Kornhuber,Piotr Lewczuk +8 more
TL;DR: The findings suggest that VILIP-1 may play a role in the AD pathophysiology and is a good candidate for dynamic biomarker of AD, although this issue requires further investigation.